Company Data
Harmony Biosciences Holdings Inc.
Ticker
HRMY
Current Price
$37.97 -0.21%
Market Cap
$2.2B
Price Target
Refer to Report
Volume
426.5K
52wk Range
$26.47 - $41.61
Overview
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.